MA47172A - Compositions et procédés de traitement des inflammations intestinales et du cancer du côlon - Google Patents

Compositions et procédés de traitement des inflammations intestinales et du cancer du côlon

Info

Publication number
MA47172A
MA47172A MA047172A MA47172A MA47172A MA 47172 A MA47172 A MA 47172A MA 047172 A MA047172 A MA 047172A MA 47172 A MA47172 A MA 47172A MA 47172 A MA47172 A MA 47172A
Authority
MA
Morocco
Prior art keywords
compositions
treatment
methods
colon cancer
intestinal inflammation
Prior art date
Application number
MA047172A
Other languages
English (en)
Inventor
Huang-Ge Zhang
Original Assignee
Univ Louisville Res Found Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Louisville Res Found Inc filed Critical Univ Louisville Res Found Inc
Publication of MA47172A publication Critical patent/MA47172A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA047172A 2016-11-22 2017-11-22 Compositions et procédés de traitement des inflammations intestinales et du cancer du côlon MA47172A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662425320P 2016-11-22 2016-11-22

Publications (1)

Publication Number Publication Date
MA47172A true MA47172A (fr) 2021-05-12

Family

ID=62144631

Family Applications (1)

Application Number Title Priority Date Filing Date
MA047172A MA47172A (fr) 2016-11-22 2017-11-22 Compositions et procédés de traitement des inflammations intestinales et du cancer du côlon

Country Status (4)

Country Link
US (4) US20180140654A1 (fr)
EP (1) EP3562496A4 (fr)
MA (1) MA47172A (fr)
WO (1) WO2018098247A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120315324A1 (en) 2010-02-05 2012-12-13 University Of Louisville Research Foundation, Inc. Exosomal compositions and methods for the treatment of disease
WO2013070324A1 (fr) 2011-11-07 2013-05-16 University Of Louisville Research Foundation, Inc. Compositions de microvésicules dérivées de plante comestible pour le diagnostic et le traitement d'une maladie
WO2015157652A1 (fr) 2014-04-11 2015-10-15 University Of Louisville Research Foundation, Inc. Compositions de microvésicule dérivée de plante comestible revêtue, et leurs procédés d'utilisation
US10815520B2 (en) 2017-04-07 2020-10-27 University Of Louisville Research Foundation, Inc. Nanovesicles, methods, and systems for diagnosis and prognosis of cancer
US12036262B2 (en) 2017-11-22 2024-07-16 University Of Louisville Research Foundation, Inc. Edible plant-derived nanoparticles for regulation of gut microbiota
US20220288130A1 (en) * 2019-08-14 2022-09-15 University Of Louisville Research Foundation, Inc. Compositions and methods for diagnosis and treatment of metabolic diseases and disorders
CN111214458A (zh) * 2020-02-27 2020-06-02 西安交通大学 一种姜黄衍生的类外泌体纳米颗粒及其制备方法
CN111643677B (zh) * 2020-05-26 2023-06-27 四川省肿瘤医院 一种包封TLR4/MyD88信号通路拮抗剂的纳米脂质体及其制备方法和应用
CN111671740A (zh) * 2020-07-28 2020-09-18 中国农业科学院农业质量标准与检测技术研究所 6-姜烯酚在制备抑制内毒素引起肝损伤的药物中的应用以及抑制内毒素引起肝损伤的药物
EP4193986A4 (fr) * 2020-08-07 2024-12-11 Exostemtech Co., Ltd. Composition cosmétique anti-âge et antioxydante contenant des exosomes de brocoli en tant que principe actif et produits cosmétiques fonctionnels la comprenant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101000470B1 (ko) * 2008-04-24 2010-12-14 강원대학교산학협력단 브로콜리 나노입자 제조방법 및 브로콜리 나노입자를함유하는 식용가능 조성물
WO2013070324A1 (fr) * 2011-11-07 2013-05-16 University Of Louisville Research Foundation, Inc. Compositions de microvésicules dérivées de plante comestible pour le diagnostic et le traitement d'une maladie
KR20130087174A (ko) * 2012-01-27 2013-08-06 제주대학교 산학협력단 브로콜리 열수추출물을 유효성분으로 함유하는 염증질환의 예방 또는 치료용 조성물
JP5808772B2 (ja) * 2013-05-13 2015-11-10 株式会社エヌ・エル・エー 肝細胞内のミトコンドリアの活性化方法
CN103655476B (zh) * 2013-12-03 2015-08-19 苏州市立医院 一种CSN8shRNA纳米脂质体的制备方法及其应用
US9717733B2 (en) * 2014-08-13 2017-08-01 University Of Louisville Research Foundation, Inc. Edible plant-derived microvesicle compositions including conjugated therapeutic agents and methods for using the same

Also Published As

Publication number Publication date
WO2018098247A1 (fr) 2018-05-31
US20180140654A1 (en) 2018-05-24
EP3562496A4 (fr) 2020-08-05
EP3562496A1 (fr) 2019-11-06
US20230181670A1 (en) 2023-06-15
US20200046788A1 (en) 2020-02-13
US20200206297A1 (en) 2020-07-02

Similar Documents

Publication Publication Date Title
MA47613A (fr) Compositions et procédés de traitement du cancer
EP3947715A4 (fr) Procédés et compositions pour le traitement du cancer
EP3894392A4 (fr) Compositions et procédés pour le traitement du cancer
EP3555077A4 (fr) Compositions et procédés pour le traitement du cancer
EP3377516A4 (fr) Procédés et compositions pour le traitement du cancer
EP3687981A4 (fr) Compositions et méthodes de traitement du cancer
EP3488001A4 (fr) Traitement du cancer
MA43135A (fr) Compositions et méthodes pour le du traitement du cancer
EP3294065A4 (fr) Procédés de traitement du cancer
EP3359157A4 (fr) Procédés et compositions pour le traitement de tumeurs et de cancers métastasés et résistants
EP3390642A4 (fr) Compositions et procédés pour le traitement de rétinite pigmentaire 18 et de rétinite pigmentaire 13
MA45675A (fr) Méthodes et compositions permettant le traitement du cancer
EP3801563A4 (fr) Matériels et procédés de traitement du cancer
EP3833340A4 (fr) Compositions et procédés de traitement de la presbytie
EP3681498A4 (fr) Méthodes et compositions pour le traitement du cancer
EP3462883A4 (fr) Compositions et méthodes pour le traitement du cancer
EP3347025A4 (fr) Méthodes et compositions pour le traitement du cancer
EP3442946A4 (fr) Procédés de traitement du cancer
EP3894561A4 (fr) Procédés de traitement du cancer
EP3697767A4 (fr) Composés et procédés de traitement du cancer
EP3403099A4 (fr) Procédés et compositions pour le traitement du cancer
EP3353204A4 (fr) Méthodes et compositions pour le traitement du cancer
EP3638293A4 (fr) Méthodes et compositions pour le traitement du cancer
EP3600285A4 (fr) Compositions topiques et méthodes de traitement
FR3017298B1 (fr) Conjugues et pro-drogues pour le traitement du cancer et de maladies inflammatoires